Journal of Nutrition and Health

The Korean Nutrition Society (한국영양학회)
권호 표지
DOI QR코드

DOI QR Code

The Effect of Isoflavone and Gamma-linolenic Acid Supplementation on Serum Lipids and Menopausal Symptoms in Postmenopausal Women

폐경 후 여성에서 이소플라본과 감마 리놀렌산의 보충 섭취가 혈중 지질 농도 및 갱년기 증상에 미치는 영향

  • Gwak, Jung-Hyun (Interdisciplinary Program: Science for Aging, Yonsei University) ;
  • Kim, Ji-Young (National Research Laboratory of Clinical Nutrigenetics/Nutrigenomics, Yonsei University) ;
  • Kim, Hyae-Jin (Department of Food and Nutrition, Yonsei University) ;
  • Shin, Dong-Hyeok (Department of Family Medicine, Mizmedi hospital) ;
  • Lee, Jong-Ho (National Research Laboratory of Clinical Nutrigenetics/Nutrigenomics, Yonsei University)
  • 곽정현 (연세대학교 노화과학협동과정) ;
  • 김지영 (연세대학교 임상영양유전 국가지정 연구실) ;
  • 김혜진 (연세대학교 식품영양학과) ;
  • 신동혁 (미즈메디병원 가정의학과) ;
  • 이종호 (연세대학교 임상영양유전 국가지정 연구실)
  • Received : 2009.10.01
  • Accepted : 2010.04.06
  • Published : 2010.04.30
Download PDF
⟨ Previous Next ⟩

Abstract

This study was performed to examine the combined effects of gamma linolenic acid and isoflavone supplementation on menopausal symptoms and serum lipids in 73 postmenopausal women. A total subjects were randomly assigned to isoflavone (30 mg) + gamma-linolenic acid (110 mg) group or placebo group. We measured menopausal symptoms by modified Kupperman Index (KI) and oxidized LDL, lipid peroxides, blood components and anthropometric parameters before and after the 12 week intervention period. After the 12 weeks of supplementation, supplement group and placebo group showed a significant reduction of modified kupperman index (p < 0.001). Isoflavone (30 mg) + gamma-linolenic acid (110 mg) supplement group showed a significant reduction of oxidized LDL cholesterol concentration (p = 0.006) whereas placebo group did not show significant change. Isoflavone and gamma-linolenic acid consumption did not significantly affect plasma concentrations of total, LDL, HDL cholesterol, triglyceride, apo A1, B and blood components. The result of present study demonstrated the supplementation of 30 mg isoflavone and 110 mg gamma-linolenic acid per day for 12 weeks may protect LDL cholesterol from oxidative stress.

본 연구 결과를 요약하면 다음과 같다. 1) 산화 LDL 농도는 이소플라본 및 감마 리놀렌산 보충군에서 유의적으로 감소 (p = 0.006), 플라시보군에서 유의적인 변화 없었음. 두 군간 비교에서 유의적인 차이가 있었음 (p = 0.011). 2) 혈청에서의 중성지방, 총 콜레스테롤, LDL 콜레스테롤, HDL 콜레스테롤, 아포지단백 A1, B 등의 농도는 두 군에서 모두 유의적인 차이가 없었음. 3) LDL particle size와 Paraoxonase 활성도는 두 군에서 모두 유의적인 차이가 없었음. 지질과산화지표인 혈장 MDA 농도는 두 군간 변화량 비교에서만 유의적인 차이가 있었음 (p = 0.010). 4) 갱년기 증상 지표인 Modified kupperman index (KI)는 이소플라본 및 감마 리놀렌산 보충군과 플라시보군에서 모두 유의적으로 감소하였음 (p < 0.001). KI 수치의 군간 비교에서는 유의적인 차이가 없었음. 이소플라본 및 감마 리놀렌산 복합제재를 12주간 섭취하였을 때 이소플라본 및 감마 리놀렌산 보충군에서 산화 LDL 농도가 유의적인 감소하였고, 두 군간의 비교시 MDA 농도 변화량의 유의적인 차이를 확인하였다. 이소플라본 및 감마리놀렌산 복합제재 섭취는 산화적 스트레스로부터 체내 LDL-콜레스테롤의 산화를 예방하는데 도움을 줄 수 있을 것으로 사료된다. 우리나라에서 폐경 후 여성을 대상으로 이소플라본 및 감마리놀렌산 복합 제재 섭취와 관련 된 연구는 매우 미흡한 실정임으로 복합제재의 용량 설정을 세분화 하고 복용기간을 연장한 후속 연구가 필요할 것으로 사료된다.

Keywords

References

  1. Yaffe K, Sawaya G, Lieberburg I, Grady D. Estrogen theraphy in postmenopausal women: effects on cognitive function and dementia. JAMA 1998; 279: 688-695 https://doi.org/10.1001/jama.279.9.688
  2. Rosano GM, Vitale C, Marazzi G, Volterrani M. Menopause and cardiovascular disease: the evidence. Climacteric 2007; 10: 19-24 https://doi.org/10.1080/13697130601114917
  3. Collins P, Rosano G, Casey C. Management of cardiovascular risk in the perimenopausal women: a consensus statement of European cardiologists and gynecologists. Climacteric 2007; 10: 508-526 https://doi.org/10.1080/13697130701755213
  4. Barentsen R. The climacteric in the Netherlands: a review of Dutch studies on epidemiology, attiudes and use of hormone replacement therapy. Eur J Obstet Gynecol Reprod Biol 1996; 64 (suppl): S7-S11 https://doi.org/10.1016/0301-2115(95)02349-6
  5. Beral V. Breast cancer and hormone-replacement theraphy in the Million Women Study. Lancet 2003; 362: 419-427 https://doi.org/10.1016/S0140-6736(03)14065-2
  6. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002; 288: 321-333 https://doi.org/10.1001/jama.288.3.321
  7. Boker LK, van der Schouw YT, de Kleijn MJ, Jasques PF, Grobbee DE, Peeters PH. Intake of dietary phytoestrogens by Dutch women. J Nutr 2002; 132: 1319-1328
  8. Morito K, Hirose T, Kinjo J. Interaction of phytoestrogens with estrogen receptors alpha and beta. Biol Pharm Bull 2001; 24: 351-356 https://doi.org/10.1248/bpb.24.351
  9. Petri Nahas E, Nahas Neto J, De Luca L, Traiman P, Pontes A, Dalben I. Benefits of soy germ isoflavones in postmenopausal women with contraindication for conventional hormone replacement therapy. Maturitas 2004; 48(4): 372-380 https://doi.org/10.1016/j.maturitas.2003.09.026
  10. Han KK, Soares JM Jr, Haidar MA, de Lima GR, Baracat EC. Benefits of soy isoflavone therapeutic regimen on menopausal symptoms. Obstet Gynecol 2002; 99(3): 389-394 https://doi.org/10.1016/S0029-7844(01)01744-6
  11. Kaari C, Haidar MA, Junior JM, Nunes MG, Quadros LG, Kemp C, Stavale JN, Baracat EC. Randomized clinical trial comparing conjugated equine estrogens and isoflavones in postmenopausal women: a pilot study. Maturitas 2006; 53(1): 49-58 https://doi.org/10.1016/j.maturitas.2005.02.009
  12. Albertazzi P, Pansini F, Bonaccorsi G, Zanotti L, Forini E, De Aloysio D. The effect of dietary soy supplementation on hot flushes. Obstet Gynecol 1997; 91(1): 6-11
  13. Cheng G, Wilczek B, Warner M, Gustafsson JA, Landgren BM. Isoflavone treatment for acute menopausal symptoms. Menopause 2007; 14: 468-473 https://doi.org/10.1097/GME.0b013e31802cc7d0
  14. Kotsopoulos D, Dalais FS, Liang YL, McGrath BP, Teede HJ. The effects of soy protein containing phytoestrogens on menopausal symptoms in postmenopausal women. Climacteric 2000; 3: 161-167 https://doi.org/10.1080/13697130008500108
  15. Wangen KE, Duncan AM, Xu X, Kurzer MS. Soy isoflavones improve plasma lipids in normocholesterolemic and mildly hypercholesterolemic postmenopausal women. Am J Clin Nutr 2001; 73: 225-231
  16. Jenkins DJ, Kendall CW, Garsetti M, Rosenberg-Zand RS, Jackson CJ, Agarwal S, Rao AV, Diamandis EP, Parker T, Faulkner D, Vuksan V, Vidgen E. Effect of soy protein foods on low-density lipoprotein oxidation and ex vivo sex hormone receptor activitya controlled crossover trial. Metabolism 2000; 49: 537-543 https://doi.org/10.1016/S0026-0495(00)80022-0
  17. Lee JH, Kim EM, Chae JS, Jang YS, Lee JH, Lee G. The effect of isoflavone supplement on plasma lipid & antioxidant status in hypercholesterolemic postmenopausal women. Korean J Nutr 2003; 36(6): 603-612
  18. Ishikawa T, Fujiyama Y, Igarashi O, Morino M, Tada N, Kagami A, Sakamoto T, Nagano M, Nakamura H. Effects of gammalinolenic acid on plasma lipoproteins and apolipoproteins. Atherosclerosis 1989; 75(2-3): 95-104 https://doi.org/10.1016/0021-9150(89)90165-2
  19. Abraham RD, Riemersma RA, Elton RA, Macintyre C, Oliver MF. Effects of safflower oil and evening primrose oil in men with a low dihomo-gamma-linolenic level. Atherosclerosis 1990; 81 (3): 199-208 https://doi.org/10.1016/0021-9150(90)90067-S
  20. Guivernau M, Meza N, Barja P, Roman O. Clinical and experimental study on the long-term effect of dietary gamma-linolenic acid on plasma lipids, platelet aggregation, thromboxane formation, and prostacyclin production. Prostaglandins Leukot Essent Fatty Acids 1994; 51(5): 311-316 https://doi.org/10.1016/0952-3278(94)90002-7
  21. Hidalgo LA, Chedraui PA, Morocho N, Ross S, San Miguel G. The effect of red clover isoflavones on menopausal symptoms, lipids and vaginal cytology in menopausal women: a randomized, double-blind, placebo-controlled study. Gynecol Endocrinol 2005; 21(5): 257-264 https://doi.org/10.1080/09513590500361192
  22. Sammartino A, Tommaselli GA, Gargano V, di Carlo C, Attianese W, Nappi C. Short-term effects of a combination of isoflavones, lignans and Cimicifuga racemosa on climacteric-related symptoms in postmenopausal women: a double-blind, randomized, placebo-controlled trial. Gynecol Endocrinol 2006; 22(11): 646-650 https://doi.org/10.1080/09513590601010722
  23. Park HM, The efficacy of phytoestrogen in postmenopausal women. J Korean Soc Menopapuse 2007; 50(3): 389-415
  24. Lee SY, Lee MJ, Yoon S, Kwon DJ. Estimated Isoflavone intake from soy products in korean middle-aged women. J Korean Soc Food Sci Nutr 2000; 29(5): 948-956
  25. Hsieh CY, Santell RC, Haslam SZ, Heiferich WG. Estrogenic effects of genistein on the growth of estrogen recepter-positive human breast cancer (MCF-7) cells in vitro and in vivo. Cancer Res 1998; 58: 3833-3838
  26. Allered CA, Allred KF, Ju YH, Virant SM, Helferich WG. Soy diets containning varying amounts of genistein stimulate growth of estrogen-dependent (MCF-7) tumors in dose-dependent manner. Cancer Res 2001; 61: 5045-5050
  27. Hankinson SE, Eliassen AH. Endogenous estrogen, testosterone and progesterone levels in relation to breast cancer risk. J Steroid Biochem Mol Biol 2007; 106: 24-30 https://doi.org/10.1016/j.jsbmb.2007.05.012
  28. Verhoeven MO, van der Mooren MJ, van de Weijer PH, Verdegem PJ, van der Burgt LM, Kenemans P. CuraTrial Research Group. Effect of a combination of isoflavones and Actaea racemosa Linnaeus on climacteric symptoms in healthy symptomatic perimenopausal women: a 12-week randomized, placebo-controlled, double-blind study. Menopause 2005; 12(4): 412-420 https://doi.org/10.1097/01.gme.0000170603.63022.62
  29. Baber RJ, Templeman C, Morton T, Kelly GE, West L. Randomized placebo-controlled trial of an isoflavone supplement and menopausal symptoms in women. Climacteric 1999; 2(2): 85-92 https://doi.org/10.3109/13697139909025571
  30. Knight DC, Howes JB, Eden JA, Howes LG. Effects on menopausal symptoms and acceptability of isoflavone-containing soy powder dietary supplementation. Climacteric 2001; 4(1): 13-18
  31. St Germain A, Peterson CT, Robinson JG, Alekel DL. Isoflavonerich or isoflavone-poor soy protein does not reduce menopausal symptoms during 24 weeks of treatment. Menopause 2001; 8 (1): 17-26 https://doi.org/10.1097/00042192-200101000-00005
  32. Dalais FS, Rice GE, Wahlqvist ML, Grehan M, Murkies AL, Medley G, Ayton R, Strauss BJ. Effects of dietary phytoestrogens in postmenopausal women. Climacteric 1998; 1(2): 124-129 https://doi.org/10.3109/13697139809085527
  33. Nagata C, Takasuka N, Kurisu Y, Shimizu H. Decreased serum total cholesterol concertration is associated with high intake of soy products in Japanese men and women. J Nutr 1998; 128: 209-213
  34. Potter SM. Overview of proposed mechanisms for the hypocholesterolemic effec soy. J Nutr 1995; 125: 606S-611S
  35. Hodgson JM, Puddey IB, Croft KD, Mori TA, Rivera J, Beilin LJ. Isoflavonoids do not inhibit in vivo lipid peroxidation in subjects with high-normal blood pressure. Atherosclerosis 1999; 145(1): 167-172 https://doi.org/10.1016/S0021-9150(99)00029-5
  36. Chio IS, Bea YJ, Jang S, Lee DH, Yun ME, Lee HS, Kim MH, Lee SH, Sung CJ. Effect of soy isoflavone supplementation and exercise on serum lipids in postmenopausal women. Korean J Nutr 2005; 38(6): 411-418
  37. Dewell A, Hollenbeck CB, Bruce B. The effects of soy-derived phytoestrogens on serum lipids and lipoproteins in moderately hypercholesterolemic postmenopausal women. J Chin Endocriol Metab 2002; 87: 118-121 https://doi.org/10.1210/jc.87.1.118
  38. Simons LA, von Konigsmark M, Simons J, Celermajer DS. Phytoestrogens do not influence lipoprotein levels or endothelial function in healthy postmenopausal women. Am J Cardiol 2000; 85: 1297-1301 https://doi.org/10.1016/S0002-9149(00)00759-1
  39. Howes JB, Sulllivan D, Lai N, Nestel P, Pomeroy S, Wesf L, Eden JA, Howes LG. The effects of dietary supplementation with isoflavones from red clover on the lipoprotein profiles of post menopausal women with mild to moderate hypercholesterolaemia. Atherosclerosis 2000; 152: 143-147 https://doi.org/10.1016/S0021-9150(99)00437-2
  40. Park BS, Zammit AV. Effect of dietary oil containg r-linolenic acid on the plasma lipid levels and thrombotic activity in rats. Korean J Nutr 2003; 36(9): 889-897
  41. Jenkins DJ, Kendall CW, Jackson CJ, Connelly PW, Parker T, Faulkner D, Vidgen E, Cunnane SC, Leiter LA, Josse RG. Effects of high- and low-isoflavone soyfoods on blood lipids, oxidized LDL, homocysteine, and blood pressure in hyperlipidemic men and women. Am J Clin Nutr 2002; 76: 365-372
  42. Tikkanen MJ, Wahala K, Ojala S, Vihma V, Adlercreutz H. Effect of soybean phytoestrogen intake on low density lipoprotein oxidation resistance. Proc Natl Acad Sci 1998; 95: 3106-3110 https://doi.org/10.1073/pnas.95.6.3106
  43. Wei H, Bowen R, Cai Q, Barnes S, Wang Y. Antioxidant and antipromotional effects of the soybean isoflavone genistein. Proc Soc Biol Med 1995; 208: 124-130
  44. Jenkins DJ, Kendall CW, Garsetti M, Rosenberg-Zand RS, Jackson CJ, Agarwal S, Rao AV, Diamandis EP, Parker T, Faulkner D, Vuksan V, Vidgen E. Effect of soy protein foods on low density lipoprotein oxidation and ex vivo sex hormone receptor activitya controlled crossover trial. Metabolism 2000; 49: 537-543 https://doi.org/10.1016/S0026-0495(00)80022-0
  45. Ruiz-Larrea MB, Mohan AR, Paganga G, Miller NJ, Bolwell GP, Rice-Evans CA. Antioxidant activity of phytoestrogenic isoflavones. Free Radic Res 1997; 26(1): 63-70 https://doi.org/10.3109/10715769709097785
  46. Arora A, Nair MG, Strasburg GM. Antioxidant activities of isoflavones and their biological metabolites in a liposomal system. Arch Biochem Biophys 1998; 356(2): 133-141 https://doi.org/10.1006/abbi.1998.0783
  47. Giles D, Wei H. Effect of structurally related flavones/ isoflavones on hydrogen peroxide production and oxidative DNA damage in phorbol ester-stimulated HL-60 cells. Nutr Cancer 1997; 29(1): 77-82 https://doi.org/10.1080/01635589709514605
  48. Cai Q, Wei H. Effect of dietary genistein on antioxidant enzyme activities in SENCAR mice. Nutr Cancer 1996; 25(1): 1-7 https://doi.org/10.1080/01635589609514423
  49. Jenkins DJ, Kendall CW, Vidgen E, Vuksan V, Jackson CJ, Augustin LS, Lee B, Garsetti M, Agarwal S, Rao AV, Cagampang GB, Fulgoni V. Effect of soy-based breakfast cereal on blood lipids and oxidized low-density lipoprotein. Metabolism 2000; 49 (11): 1496-1500 https://doi.org/10.1053/meta.2000.17703

Cited by

  1. Effective Anti-aging Strategies in an Era of Super-aging vol.20, pp.3, 2014, https://doi.org/10.6118/jmm.2014.20.3.85